Bafna Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 ,inter alia, to consider and approve the Audited Financial ....
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bafna Pharmaceuticals has informed BSE and NSE that its Board of Directors will meet on May 26, 2025. The primary agenda is to consider and approve the Audited Financial Results for the quarter and full year ended March 31, 2025. The company has also notified that the trading window for designated persons and their immediate relatives remains closed from April 1, 2025 to May 28, 2025. This is a routine compliance intimation under SEBI's Listing Regulations and does not contain any actual financial figures.
This is a procedural announcement with no direct impact on the stock price. Shareholders should watch for the actual audited results on or after May 26, 2025, which will reveal the company's full-year FY25 financial performance.